Medicine used for assisting interventional therapy of liver cancer

Abstract

The invention discloses a medicine used for assisting interventional therapy of liver cancer, belonging to the field of traditional Chinese medicines. The active ingredients of the medicine disclosed by the invention are composed of the following raw materials in the parts by weight: 65-90 parts of salvia miltiorrhiza, 55-75 parts of grifola, 50-65 parts of semen plantaginis, 45-60 parts of astragalus mongholicus, 40-55 parts of herba lycopi, 35-50 parts of rhizoma alismatis, 30-45 parts of semen lepidii, 27-43 parts of Chinese yam, 24-38 parts of curcuma zedoary, 20-35 parts of exocarpium citrulli, 18-32 parts of caulis spatholobi, 15-28 parts of donkey-hide gelatine, 13-25 parts of tortoise plastron, 10-18 parts of turtle shell, 6-15 parts of pericarpium arecae, and 3-12 parts of magnolia obavata. The medicine disclosed by the invention is excellent in prescription, used for balancing internal secretion, tonifying spleen and warming the kidney aiming at pathogenesis causing liver depression of liver cancer, qi stagnation, blood stasis, liver and kidney yin deficiency, spleen and kidney yang deficiency, and the like, and for the purposes of regulating qi and dissolving stasis, clearing heat and relaxing bowel, as well as activating blood circulation and tonifying qi, remarkable in curative effect via clinical verifications, capable of alleviating the side effects of chemotherapy and radiotherapy, and suitable for adjuvant therapy of clinical liver cancer intervention.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for assisting interventional treatment of liver cancer. Background technique [0002] Liver cancer refers to malignant tumors that occur in the liver, including primary liver cancer and metastatic liver cancer. It is one of the most common malignant tumors in clinical practice. Typical symptoms are obvious loss of appetite, dull pain in the upper right quadrant, fatigue and weight loss, jaundice, and ascites , skin itching, etc. At present, the clinical treatment of liver cancer is surgical treatment first, through the complete removal of tumor tissue to achieve the goal of cure, but there is also the risk of recurrence and metastasis, in addition to radiofrequency ablation, microwave ablation, high-intensity focused ultrasound, arterial chemoembolization, alcohol Injection, cryotherapy, radiotherapy, molecular targeted therapy, immunotherapy and other meth...

AI Technical Summary

Problems solved by technology

Interventional therapy for liver cancer is a targeted therapy with definite curative effect, scientific mechanism, simple operation, safe and reliable, and is also suitable for elderly and infirm patients and patients with certain diseases at the same time. The diagnostic imaging is clear and can be repeated. Relatively low, but there are also problems such as obvious side effects, incomplete killing of cancer cells, and high difficulty in operation